semaglutide for weight loss sandy Medical UT Tirzepatide & Semaglutide for Weight

While a 2024 FDA Drug Safety Communication did not find an increased association between depressive symptoms and suicidal thoughts in patients taking GLP-1 RAs, it nonetheless recommended that patients be closely monitored for such symptoms until more data is available

He started prescribing GLP-1s off-label after some of his patients started taking the drugs for weight loss but were also reporting less fatigue

doi: 10.3389/fnut.2022.1027629, 182

Our medical team takes on the responsibility of verifying your insurance coverage, ensuring the weight loss medication is covered by insurance, and managing prior authorization so you can focus on your wellness journey